(PRESS RELEASE) PARIS, 12-Apr-2022 — /EuropaWire/ — Diabeloop, a pioneer in the field of therapeutic artificial intelligence, leverages the potential of its diabetes technology to enable the integration of insulin pens into its hybrid closed-loop system using a unique app. … Read the full press release
Posted in Denmark, France, Healthcare, News, Pharma & Biotech, Spain, Technology
Tagged aid, automated insulin delivery, BIOCORP, DBL-4pen, DBL-hu, DBLG1, Diabeloop, Diabetes, Erik Huneker, insulin pen, insulin therapy, Mallya®, Marc Julien, multiple daily insulin injections, Prof. Hélène Hanaire, Seagrove Partners, Simon-Kucher, smart pen, Stéphanie JEGU, therapeutic AI, type 1 diabetes, type 2 diabetes, University Hospital of Toulouse, YourLoops
(PRESS RELEASE) PARIJS, 2-Jun-2021 — /EuropaWire/ — Vanaf het begin heeft Diabeloop innovatieve systemen ontwikkeld om de behandeling van diabetes type 1 te automatiseren en te personaliseren, waarbij altijd rekening wordt gehouden met de optiek van de patiënt. Het Franse … Read the full press release
Posted in Belgium, France, Healthcare, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged algoritme, ATTD 2021, ATTD2021, Bernhard Gehr, CEA-Leti, CERITD, DBLG1, DBLG1 AID-systeem, DBLG1 System, DBLG1 System met Accu-Check Insight, DBLG1-algoritme, Diabeloop, Diabetes, diabetes type 1, diabetesbehandeling, diabetologen, diabetoloog, Dr. Guillaume Charpentier, Erik Huneker, gepersonaliseerde behandeling, insulinedosis, m&i Fachklinik Bad Heilbrunn, Marc Julien, Nicole Wetzels, Roche Diabetes Care, T1D, Yousra Tourki, zelflerend algoritme
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
